Richard L. Schilsky, MD—who’s led ASCO’s charge in urging Congress to take notice of the increasing scarcities of needed cancer drugs—discusses the three big ways the shortages affect the cancer care community.

Hear what Schilsky, now ASCO’s Chief Medical Officer, told OT.